Stock ITOS ITEOS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases iTeos Therapeutics, Inc.

Equities

ITOS

US46565G1040

Real-time Estimate Cboe BZX
Other stock markets
 10:02:23 2024-06-06 am EDT 		5-day change 1st Jan Change
16.99 USD -2.36% Intraday chart for iTeos Therapeutics, Inc. +0.06% +56.71%
May. 13 HC Wainwright Adjusts Price Target on iTeos Therapeutics to $46 From $44, Maintains Buy Rating MT
May. 10 Wedbush Adjusts iTeos Therapeutics' Price Target to $21 From $18, Maintains Outperform Rating MT

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
ITeos Therapeutics Announces $120 Million Registered Direct Offering
AQ
ITeos Reports First Quarter 2024 Financial Results and Provides Business Updates
AQ
ITeos Therapeutics : SECURITIES PURCHASE AGREEMENT - Form 8-K
PU
ITeos Reports First Quarter 2024 Financial Results and Provides Business Updates
GL
ITeos Therapeutics Announces $120 Million Registered Direct Offering
GL
ITeos Therapeutics Announces $120 Million Registered Direct Offering
AQ
ITeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024
AQ
ITeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024
GL
ITeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
GL
ITeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors
GL
ITeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
AQ
ITeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors
AQ
ITeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024
GL
ITeos to Participate in Upcoming Investor Conferences
GL
ITeos Announces 2024 Strategic Priorities and Anticipated Milestones
GL
ITeos Announces 2024 Strategic Priorities and Anticipated Milestones
AQ
NiKang Therapeutics Appoints Joanne Lager, M.D., as Chief Medical Officer
AQ
ITeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference
AQ
ITeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference
GL
ITeos to Present at the Piper Sandler 35th Annual Healthcare Conference
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ITOS Stock
  4. News iTeos Therapeutics, Inc.
  5. Press Releases